期刊文献+

Reversal of Multi-Drug Resistance by Vector-Based-ShRNA-Mdr1 In Vitro and In Vivo

Reversal of Multi-Drug Resistance by Vector-Based-ShRNA-Mdr1 In Vitro and In Vivo
下载PDF
导出
摘要 In order to investigate the effects of vector-based hairpin small interference RNA (shRNA) on the reversal of multi-drug resistance (mdr) of A2780/Taxol cells, a novel vector pEGFP-HI/mdrl containing mdrl-shRNA targeting at position 2943-2963 of mdrl was designed and synthesized. Subsequently, A2780/Taxol cells were transfected with pEGFP-H1/rndrl, and the expression ofmdrl mRNA and P-gp was detected by using RT-PCR and Western blot respectively. MTT was used to measure the 50% inhibition concentration (IC50) of Taxol to A2780/Taxol cells. The results showed that at the 24th and 48th h after transfection, the expression of mdrl mRNA was decreased to (52.1±1.0)% and (0.01±1.7)%, and that of P-gp decreased to (88.3±2.1)% and 0%, respectively. At the 48th h after transfection, the relative reversal rate of A2780/Taxol cells to Taxol was 69.54%. In vivo, the nude mice xenografts were injected with pEGFP-H1/mdrl, and then administrated Taxol. The tumor volume in pEGFP-H1/mdrl-transfected group was significantly reduced as compared with that in blank control group or pEGFP-Hl-transfected group (807.20±103.16 vs 1563.78±210.54 or 1480.78±241.24 mm^3, both P〈0.01). These results suggested that transfection of pEGFP-HI/mdrl could efficiently down-regulate the expression of mdrl mRNA and P-gp in A2780/Taxol cells, and effectively restore the sensitivity of A2780/Taxol ceils to Taxol both in vitro and in vivo. In order to investigate the effects of vector-based hairpin small interference RNA (shRNA) on the reversal of multi-drug resistance (mdr) of A2780/Taxol cells, a novel vector pEGFP-HI/mdrl containing mdrl-shRNA targeting at position 2943-2963 of mdrl was designed and synthesized. Subsequently, A2780/Taxol cells were transfected with pEGFP-H1/rndrl, and the expression ofmdrl mRNA and P-gp was detected by using RT-PCR and Western blot respectively. MTT was used to measure the 50% inhibition concentration (IC50) of Taxol to A2780/Taxol cells. The results showed that at the 24th and 48th h after transfection, the expression of mdrl mRNA was decreased to (52.1±1.0)% and (0.01±1.7)%, and that of P-gp decreased to (88.3±2.1)% and 0%, respectively. At the 48th h after transfection, the relative reversal rate of A2780/Taxol cells to Taxol was 69.54%. In vivo, the nude mice xenografts were injected with pEGFP-H1/mdrl, and then administrated Taxol. The tumor volume in pEGFP-H1/mdrl-transfected group was significantly reduced as compared with that in blank control group or pEGFP-Hl-transfected group (807.20±103.16 vs 1563.78±210.54 or 1480.78±241.24 mm^3, both P〈0.01). These results suggested that transfection of pEGFP-HI/mdrl could efficiently down-regulate the expression of mdrl mRNA and P-gp in A2780/Taxol cells, and effectively restore the sensitivity of A2780/Taxol ceils to Taxol both in vitro and in vivo.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第5期620-624,共5页 华中科技大学学报(医学英德文版)
基金 supported by grants from National Natural Sciences Foundation of China (No.30070786) Scientific Research Foundation of Hubei Health Department (No.JX2B17) Key Technologies R&D Programme of Hubei Province,China (No.2007AA301C20)
关键词 RNA interference multi-drug resistance gene therapy RNA interference multi-drug resistance gene therapy
  • 相关文献

参考文献10

  • 1Lu S,Wang X,Cai L,et al.Inhibition of MDR1 gene by hairpin siRNA to reversal of multi-drug resistance in ovarian cancer cells[].Chinese Journal of Obstetrics and Gynecology.2007
  • 2Stein U,Walther W,Stege A,et al.Complete in vivo reversal of the multidrug resistance phenotype byJet-injection of anti-MDR1 short hairpin RNA-en-coding plasmid DNA[].Molecular Therapy.2008
  • 3Hannon1 GJ,Rossi JJ.Unlocking the potential of the human genome with RNA interference[].Nature.2004
  • 4Luan YZ,Li L,Li D,et al.Development of five kinds of drug-resistant ovarian cancer cell lines and expres-sion of partial resistance-related genes[].Chinese Journal of Obstetrics and Gynecology.2004
  • 5Thomas H,Coley HM.Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein[].Cancer Control.2003
  • 6Yusuf R Z,Duan Z,Lamendola D E,et al.Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation[].Current Cancer Drug Targets.2003
  • 7Roninson IB,Chin JE,Choi KG,et al.Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells[].Proceedings of the National Academy of Sciences of the United States of America.1986
  • 8Masanek U,Stammler G,Volm M.Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides[].Journal of Experimental Therapeutics & Oncology.2002
  • 9Nagata J,Kijima H,Hatanaka H,et al.Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene[].International Journal of Oncology.2002
  • 10Ramachandran C,Wellham L L.Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts[].Anticancer Research.2003

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部